Zacks Investment Research on MSN
Is Invesco Biotechnology & Genome ETF (PBE) a strong ETF right now?
The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. What ...
Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional ...
The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...
Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GATC Health, a leading tech-bio company leveraging artificial intelligence ...
Investor's Business Daily on MSN
China biotech lights up. US stocks prepare for a new powerhouse.
U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the ...
The biotech sector has found its footing again after several difficult years. The equal-weighted S&P Biotechnology ETF (XBI) has staged an impressive rebound, helped by a revival in risk appetite, ...
Biotech stocks have a way of making smart people do dumb things. It starts innocently enough. You read about a "breakthrough" that sounds like it came straight out of science fiction. A tiny company ...
BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announces the launch of Derisq™, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results